Skip to main content
. 2016 Feb 5;8(2):231–243. doi: 10.18632/aging.100872

Figure 4. Loss of filamentous structures in AZD8055-treated cells.

Figure 4

Fibroblasts at CPD 73 exposed to 35 nM or 70 nM AZD8055 or equivalent volume of DMSO for 1 week were fixed and stained using sulforhodamine B, then imaged by phase contrast microscopy. Left panel imaged with X40 objective; right panel magnification of regions outlined by black boxes.